• ESCMID
  • CMI
  • EUCAST Newsletter
  • EUCAST News
Search
EUCAST
menu
Back Close
  • About EUCAST
    About EUCAST
    • Overview
    Close
    Organisation
    • Overview
    • Steering Committee
    • General Committee
    • EUCAST Statutes
    • National AST Committees (NAC)
    • Network Laboratories
    • Development Laboratories (EDL)
    • View all
    Subcommittees
    • Overview
    • Antimycobacterial Susceptibility Testing (AMST)
    • Antifungal Susceptibility Testing (AFST)
    • Veterinary Subcommittee on Antimicrobial Susceptibility Testing (VetCAST)
    • Phage Susceptibility Testing Subcommittee (PST)
    • Subcommittee on WGS and Phenotypic AST
    • View all
    Meetings
    • Overview
    • Steering Committee Meetings
    • General Committee Meetings
    Public Consultations
    • Overview
    SOPs
    • Overview
    IVDR and EUCAST
    • Overview
    News
    • Overview
    Publications and Presentations
    • Overview
  • Bacteria
    Bacteria
    • Overview
    Close
    Clinical Breakpoints and Interpretation
    • Overview
    • Clinical Breakpoint Tables
    • Definition of S, I and R
    • When there are no breakpoints?
    • Breakpoints in Brackets
    Guidance Documents
    • Overview
    Important Additional Information
    • Overview
    • Expert Rules
    • Expected Phenotypes
    • Resistance Detection
    MIC and Zone Distributions, ECOFFs
    • Overview
    Methodology and Instructions
    • Overview
    • Disk Diffusion and Quality Control
    • MIC Determination
    • Warnings
    • Media Preparation
    • Disk Diffusion Implementation
    • EUCAST Panels of Phenotypically Defined Strains
      • Overview
      • EUCAST Panel of S. pneumoniae and betalactam agents
      • EUCAST Panel of nine well characterized P. aeruginosa strains
    • IVDR and EUCAST
    • View all
    Rapid AST in blood culture
    • Overview
    • Rapid AST directly from blood culture bottles
    • Methods and Quality Control
    • Breakpoints for Rapid AST
    • Resistance Detection in RAST
    • RAST FAQ
    • RAST MIC:zone diameter correlations
    • RAST Publications
    • View all
    Development of Clinical Breakpoints and ECOFFs
    • Overview
    • About Clinical Breakpoints
    • Setting Breakpoints
    • Public Consultations
    • Rationale Documents
    • MIC:Zone Diameter correlations
    • Technical Notes on Antibacterial Agents
    • View all
    FAQ and EDL Services
    • Overview
    • FAQ
    • EDL MIC Testing Services
  • Mycobacteria (AMST)
    Mycobacteria (AMST)
    • Overview
    Close
    Subcommittee
    • Overview
    Clinical Breakpoints and Interpretation
    • Overview
    MIC distributions and ECOFFs
    • Overview
    Development of Clinical Breakpoints and ECOFFs
    • Overview
    • Public Consultations
    • Rationale Documents
    Methodology and Instructions
    • Overview
    • Reference Method
    • Mycobacteria FAQ
    • Warnings
    • IVDR and EUCAST
    Publications and Presentations
    • Overview
  • Fungi (AFST)
    Fungi (AFST)
    • Overview
    Close
    Subcommittee
    • Overview
    Clinical Breakpoints and Interpretation
    • Overview
    • Clinical breakpoint table
    • When there are no antifungal breakpoints
    Development of clinical breakpoints and ECOFFs
    • Overview
    • Rationale documents
    • Public consultations
    Methodology and Instructions
    • Overview
    • AST of Yeasts
    • AST of Moulds
    • AST of Dermatophytes
    • Warnings
    • Quality Control
    • IVDR and EUCAST
    • View all
    Publications and Presentations
    • Overview
    • Technical Notes on Antifungal Agents
  • VetCAST
    VetCAST
    • Overview
    Close
    Subcommittee
    • Overview
    MIC distributions and ECOFFs
    • Overview
    Development of clinical breakpoints and ECOFFs
    • Overview
    • Rationale Documents
    Publications and presentations
    • Overview
  • Industry
    Industry
    • Overview
    Close
  • Education
    Education
    • Overview
    Close
Search
  • ESCMID
  • CMI
  • EUCAST Newsletter
  • EUCAST News
Frequent searches
  • breakpoints
  • rationale documents
  • expected phenotypes
  • public consultation
  • endocarditis pathogens
  • guidance documents
Suggestions
  1. Home
  2. Search

Search Results

General

Consultation: benzylpenicillin breakpoints for S.pneumoniae and Viridans group streptococci

EUCAST consultation (3 May - 14 June) on breakpoints for Streptococcus pneumoniae and viridans group streptococci.

Get to know more

Breakpoint tables and dosages v 12.0 (2022) published

The revised breakpoint table (v 12.0) and dosages now published. Valid from 1 January, 2022.

Get to know more

Comments to consultations and EUCAST response

There were comments (and now EUCAST response) to consultations on fosfomycin, piperacillin-tazobactam, Achromobacter, Bacillus spp breakpoints.

Get to know more

Updated clinical breakpoints, dosages, QC and methods documents

The yearly update of clinical breakpoint tables , QC tables , disk diffusion methods documents now available.

Get to know more

National AST Committees (NAC)

National AST Committees (NAC) EUCAST recommends that countries form a “National Antimicrobial Susceptibility Testing Committee” (or a committee corresponding to this description). Developing a NAC in a Country can be useful when adopting or implementing EUCAST antimicrobial susceptibility testing…

Get to know more

Comments and responses to the consultation on pneumococci and viridans streptococci

EUCAST comments and responses to the public consultation on changing breakpoints for S. pneumoniae and Streptococcus viridans published.

Get to know more

Breakpoint Table v 12.0 (2022) on consultation

Next year´s breakpoint table, v 12.0 , is on consultation from 3 - 20 December 2021

Get to know more

Rapid AST directly from blood culture bottles

Rapid AST directly from blood culture bottles EUCAST has developed a method for rapid AST (reading at 4, 6 or 8h and since April 2022 also after 16-20 hours incubation) directly from positive blood culture bottles (RAST). The rationale is available in JAC . Following the initial development,…

Get to know more

The 13.0 versions of breakpoints, dosing and QC (2023) published.

Breakpoint table v 13.0 , dosing table v 13.0 and QC tables v 13.0 (2023) published.

Get to know more

RAST from EUCAST updated to include Salmonella enterica

RAST breakpoints and methods were developed further to include Salmonella enterica in systemic infections. Some QC criteria were also updated.

Get to know more
Show more results
© EUCAST 2025. All rights reserved EUCAST.
ContactSitemapPrivacy NoticeDisclaimerCookies

Welcome to the new EUCAST website!

We’ve prepared a short video to help you get familiar with the new layout and features.

Watch the video here